Figure 3
From: Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision
Disease free survival by MMR and CIMP in patients treated with 5-FU. Survival curves related to Cox proportional hazard regression with respect to DNA mismatch repair (MMR) status in a) and CpG island methylator phenotype (CIMP) in b). dMMR, deficient DNA mismatch repair; pMMR, proficient DNA mismatch repair; CIMP-High, presence of CpG island methylator phenotype; CIMP-Low, presence of low levels of methylation; CIMP-0, absence of CpG island methylator phenotype.